Crossmark

Silibinin efficacy in a rat model of pulmonary arterial hypertension using monocrotaline and chronic hypoxia

Crossref DOI link: https://doi.org/10.1186/s12931-019-1041-y

Published Online: 2019-04-25

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Tingting

Kawaguchi, Nanako https://orcid.org/0000-0002-6518-3181
Yoshihara, Kenji

Hayama, Emiko

Furutani, Yoshiyuki

Kawaguchi, Kayoko

Tanaka, Takeshi

Nakanishi, Toshio
License Information

Text and Data Mining valid from 2019-04-25
More Information

Article History

Received: 22 November 2018

Accepted: 2 April 2019

First Online: 25 April 2019

Ethics approval

: All animal experiment protocols were approved by the Institutional Animal Experiment Committee of the Tokyo Women’s Medical University (AE18–111). All animal procedures were conducted in accordance with the ethical standards of the institution and conform to the guidelines from Directive 2010/63/EU of the European Parliament on the protection of animals used for scientific purposes or the current NIH guidelines (NIH publication No 85–23).

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.